TrialInternational journal of clinical oncology2011

Effects of intravenous zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from non-small cell lung cancer.

Filippo Francini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.